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Abstract 
 
Background: The main objective of the current research work was to investigate the antitumor and apoptotic effects of 
chrysanthemin in PC-3 human prostate cancer cells.  
Materials and Methods: MTT assay was used to evaluate the effects of chrysanthemin on cell viability whereas flow 
cytometry along with fluorescence microscopy were used to study apoptotic induction in these cells. Effects on caspase 
activation were detected through western blot assay.  
Results:Results showed that chrysanthemin inhibited cancer cell growth in PC-3 cancer cells in a time-dependent as well as 
concentration-dependent manner. Chrysanthemin-treated cells at 10, 50 and 150 µM doses led to 34.2%, 56.7% and 69.1% 
apoptosis in these cells respectively.The percentage of cells with depolarized mitochondria increased from 5.3% in 
untreated control cells to 27.2%, 57.6% and 86.9% in cells treated with 10, 50 and 150 µM dose of chrysanthemin 
respectively. Chrysanthemin also enhanced the activity of all three caspases viz., caspase-3, 8 and 9 in a dose-dependent 
fashion. 
Conclusions: The study concluded that chrysanthemin ledanticancer effects in PC-3 prostate cancer cells by inducing 
apoptosis, activating caspasesignaling pathway and loss of mitochondrial membrane potential. 
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Introduction 
  
Prostate cancer is a leading cause of cancer-related mortalitywithin the United States and many other Western 
countries. This disease is one of the most common health problem affecting men across the globe (Cooperberg., 2014). It is 
usually diagnosed after 60 or 70 years of age and this allows greater opportunity for its prevention or slowing its 
progression.It has been reported that 50% of prostate cancer patients ultimately develop metastatic prostate carcinoma due 
to non-availability of effective treatment plan(Greenlee et al., 2001; Whittemore et al., 1995). Existing treatment plan 
include:surgical resection, chemotherapy or radiotherapy for localized tumor. Androgen ablation constitutes one of the 
basic treatment regimen for metastatic prostate cancer patients because of its ability to induce cell cycle arrest and apoptotic 
cell death in prostate tumor cells. Most of these therapies are only effective at the initial stages of the disease but in the 
advanced stages of prostate cancer, these treatment strategies fail and the patients ultimately die (Chen & Zhao., 2013; 
Nobili et al., 2009; Karantanos et al., 2013).  
 According to World Health Organization (WHO), about 80% of the global population relies heavily on traditional 
medicines for meeting their primary healthcare needs. There are ample evidences that phytochemicals have the ability to 
provide significant protection against various kinds of cancers including prostate cancer. Natural products can be developed 
into promising anticancer drugs because of their relatively less toxicity and inhibiting the development of different types of 
carcinomas. There are various biochemical mechanisms through which these natural products and other plant extracts exert 
their anticancer effects and these include apoptosis induction, cell cycle arrest, disruption of mitochondria, DNA 
fragmentation, caspase activation, modulation of PI3K/Akt signalling pathways (Reed., 2002; Etiana et al., 2016; Shaista et 
al., 2015; Mahmoud et al., 2014).  
The aim of the present research work was to study the antitumor effects of chrysanthemin against PC-3 human prostate 
cancer cells by assessing its effects on apoptosis, caspase signalling pathway and loss of mitochondrial membrane potential.  
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Materials and Methods 
Chemicals 
 
 Chrysanthemin (≥ 95% purity as determined by HPLC), MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), dimethyl sulfoxide, 5% heat-inactivated fetal calf serum, penicillin, streptomycin were 
purchased from Thomas Scientific, High Hill Road, Swedesboro, U.S.A. Acridine orange (AO)/ethidium bromide (ETBR), 
propidium iodide and rhodamine-123 were purchased from Wuhan Boster Biological Technology Ltd. (Wuhan, China).  
 
Cell line and cell culture medium  
 
 The PC-3 human prostate cancer cell line was purchased from Institute of Biochemistry and Cell Biology, 
Shanghai Institute for Biological Sciences, Chinese Academy of Sciences. The cell culture conditions comprised of 
Minimum Essential Medium (MEM) and RPMI supplemented with 10% (v/v) fetal bovine serum (FBS) under humidified 
atmosphere of 5% CO2 at 37 oC. 
 
Cell proliferation assay 
 
 Human prostate cancer cells were plated at cell density of 2x106 cells/well in a 96-well culture plate. Different 
concentrations (0, 10, 50, 75, 100, 150 and 200 µM) of chrysanthemin in dimethyl sulfoxide (DMSO) were prepared. The 
cells were treated with the doses as stated above, and then a 10 µl solution of MTT was added to each well. The cells were 
then incubated for different time intervals including 24, 48 and 72 h. Absorbance was measured on a microplate reader 
(ELX 800; Bio-tek Instruments, Inc., Winooski, VT, USA) at a wavelength of 490 nm and the growth inhibition ratio was 
calculated. The half-maximal inhibitory concentration values (IC50) were obtained from the MTT viability curves. 
 
Annexin V-FITC assay for cell apoptosis  
 
 In brief, PC-3 human prostate cancer cells at a density of 2x106 cells per ml were seeded into a 12-well plate and 
then put on incubation for 12 h. The cells were treated with 0, 10, 50 and 150 µM dose of chrysanthemin for 48 h, washed 
with PBS and then resuspended in binding buffer comprising of Annexin V-fluorescein isothiocyanate and propidium 
iodide for 20 min. DMSO (0.50 %) dissolved in cell media served as control. Finally, the cells were analyzed by FACS 
Calibur instrument (BD Biosciences, San Jose, CA, USA) equipped with Cell Quest 3.3 software. 
 
Fluorescence microscopic study of apoptosis  
 
 The fact that chrysanthemin induced apoptosis in PC-3 human prostate cancer cells was further evaluated by using 
fluorescence microscopy involving acridine orange/propidium iodide double dye. In short, PC-3 human prostate cancer 
cells at a density of 2x106 cells/well were plated and then treated with 0, 10, 50 and 150 µM dose of chrysanthemin for 48 
h. Then both groups of cells (untreated and treated cells) were incubated with 5 μg/ml each of acridine orange and 
propidium iodide for 1 h. Then using a fluorescent microscope (400 x magnification, Nikon, Tokyo, Japan), the apoptotic 
features induced by the drug were evaluated.  
 
Measurement of Mitochondrial Membrane Potential (ΛΨm) loss 
 
 The fact that chrysanthemin induced loss of mitochondrial membrane potential was evaluated by using flow 
cytometer combined with rhodamine-123 dye. In brief, PC-3 human prostate cancer cells were seeded at a density of 2x106 
cells/ml, treated with 0, 10, 50 and 150 µM dose of chrysanthemin for 48 h and then washed with PBS and then harvested. 
A 10 µl solution of rhodamine-123 was added to the cell suspension and then analyzed by flow cytometry (FACS Calibur 
instrument (BD Biosciences, San Jose, CA, USA) equipped with Cell Quest 3.3 software).  
 
Western blot analysis 
 
 In order to evaluate the changes in the expression levels of caspase-related proteins, western blot assay was used as 
already described previously (Xu et al., 2013). The cells were treated with varying doses of chrysanthemin for 24 h and 
then the treated cells were collected and then lysed using lysis buffer. The cells were then centrifuged at 15,000 g for 20 
min. Subsequently the supernatant was collected and then using BCA method, the protein content was estimated. The 
protein was then mixed with loading buffer and incubated for 10 min at 90 oC. The cell lysates were analyzed with primary 
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antibodies of caspase-3, caspase-8 and caspase-9. Using ECL Western detection reagents, protein expressions were 
evaluated using Image Lab analysis software (Bio-Rad). 
 
Statistical analysis 
 
 Data are presented as the mean ± SEM of the control. All experiments were repeated at least three times. The 
differences between groups were analyzed by one-way ANOVA with Tukey’s posthoc tests, significance of difference was 
indicated as *P < 0.05, **P < 0.01. 
 
Results  
Chrysanthemin exerts potent antitumor effects in PC-3 human prostate cancer cells 
 
 Chrysanthemin, which is the 3-glucoside of cyanidin belongs to the anthocyanin class of natural products and its 
chemical structure is shown in Fig.1.  MTT assay showed that chrysanthemin has the tendency to exert growth inhibitory 
effects in PC-3 cancer cells. The cytotoxic effects of chrysanthemin against PC-3 human prostate cancer cells were 
evaluated at varying doses as well as different time intervals. Results indicated that chrysanthemin induces dose-dependent 
and time-dependent cytotoxic effects in PC-3 cancer cells. The MTT results are shown in figure 2 and indicate that 150 and 
200 µM doses of chrysanthemin exhibited 65.3 and 92.5% inhibitory effects respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Chemical structure of chrysanthemin (also known as Glucocyanidin). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Cytotoxic effect of chrysanthemin in PC-3 human prostate cancer cells. The cells were exposed to varying doses 
of the drug at different time intervals. Data are shown as the mean ± SD of three independent experiments. *, P < 0.05, **, 
P < 0.01, vs 0 µM (control). 
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Chrysanthemin induces apoptosis in PC-3 human prostate cancer cells 
 
 The fact that chrysanthemin induces early and late apoptosis in PC-3 human prostate cancer cells was evaluated by 
flow cytometry using annexin V as a probe. The results which are shown in figure 3 indicate that in comparison to the 
untreated control cells which do not show any signs of apoptosis, chrysanthemin-treated cells at 10, 50 and 150 µM doses 
led to 34.2%, 56.7% and 69.1% apoptosis in these cells respectively. R1, R2, R3 and R4 in figure 3 indicate necrotic cells, 
late apoptotic cells, viable cells and early apoptotic cells respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Evaluation of apoptosis induction by chrysanthemin in PC-3 human prostate cancer cells by annexin v assay. The 
cells were treated with 0, 10, 50 and 150 µM dose of chrysanthemin for 48 h and then analyzed by flow cytometry. R1, R2, 
R3 and R4 indicate necrotic cells, late apoptotic cells, viable cells and early apoptotic cells respectively. 
 
Fluorescence microscopy study of apoptosis induction by chrysanthemin in PC-3 cells 
 
 Further experiments using fluorescence microscopy in combination with acridine orange and propidium iodide 
were carried out in order to confirm apoptosis induced by chrysanthemin in human prostate cancer cells. The results of this 
assay are shown in figure 4 and reveal that untreated control cells showed normal cellular morphology with no obvious 
signs of morphological features of apoptosis (Fig.4 A). However, on treating PC-3 cells with 10, 50 and 150 µM dose of 
chrysanthemin, significant and divulging signs of apoptosis were seen including chromatin condensation and cell shrinkage. 
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Viable cells emit completely green fluorescence in this assay while as apoptotic cells emit orange/red fluorescence. As is 
evident, the number of cells emitting red fluorescence increased with increasing concentration of chrysanthemin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Apoptotic effects of chrysanthemin on the PC-3 human prostate cancer cells were evaluated by fluorescence 
microscopy using acridine orange/propidium iodide double dye. The cells were treated with 0, 10, 50 and 150 µM dose of 
chrysanthemin for 48 h and then analyzed under the microscope at a magnification of x400. White arrows indicate the cells 
which have undergone early and late apoptosis.  
 
Chrysanthemin induced loss of mitochondrial membrane potential in PC-3 cells 
 
 As mitochondrial membrane potential is a key factor in regulating cellular metabolism in all cells, next we 
observed the effect of chrysanthemin on the mitochondrial transmembrane potential in human prostate cancer cells.  For 
this purpose, rh-123 which is a fluorescent dye was used in combination with flow cytometer. Results revealed that 
chrysanthemin led to a dose-dependent loss of mitochondrial membrane potential. The percentage of cells with depolarized 
mitochondria increased from 5.3% in untreated control cells to 27.2%, 57.6% and 86.9% in cells treated with 10, 50 and 
150 µM dose of chrysanthemin respectively (Figure 5 A-D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Chrysanthemin induced loss of mitochondrial membrane potential in PC-3 human prostate cancer cells. The cells 
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after treatment with 0 (A), 10 (B), 50 (C) and 150 (D) µM dose of chrysanthemin for 48 hr were incubated with rh-123 
fluorescent dye and then analyzed by flow cytometer.  
 
Chrysanthemin induced upregulation of caspase-3, caspase-8 and caspase-9  
 
 Caspases play an important role in apoptosis induction in cells. Further, we designed our experiment in order to 
evaluate the effects of chrysanthemin on the expression levels of caspase-3, caspase-8 and caspase-9 using western blot 
assay. The results are shown in figure 6 indicating that chrysanthemin enhanced the activity of all three caspases viz., 
caspase-3, 8 and 9. The upregulating effect of chrysanthemin was found to be dose-dependent. As compared to the control, 
drug-treated groups showed higher protein expression levels which increased further as the dose increased. Thus, the 
apoptotic effect of chrysanthemin in human prostate PC-3 cancer cells could be thought to be mediated via involvement of 
the different caspases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Chrysanthemin led to upregulation of different caspases in PC-3 cancer cells. Western blot method was used to 
analyze the changes in caspase protein expressions. The cells were treated with 0, 10, 50 and 150 µM dose of 
chrysanthemin for 48 h. β-actin was used as an internal control.  
 
 
Discussion 
 
 The main objective of the present research work was to demonstrate the antitumor properties of chrysanthemin in 
PC-3 human prostate cancer cells using MTT cell viability assay. The effects on apoptosis induction, mitochondrial 
membrane potential and caspase activity were also examined. Chrysanthemin was revealed to exert growth inhibitory 
effects in PC-3 human prostate cancer cells in a time-dependent as well as dose-dependent fashion. Furthermore, it was 
observedthat chrysanthemin has the propensity to induce early and late apoptosis in PC-3 human prostate cancer cells. The 
percentage of cells which emitted red/orange fluorescence was shownto increase with increasing doses of chrysanthemin. 
As comparedto the untreated control cells which do not exhibit any signs of apoptosis, chrysanthemin-treated cells at 10, 50 
and 150 µM doses led to 34.2%, 56.7% and 69.1% apoptosis in these cells respectively. Chrysanthemin also led to 
depolarization of the mitochondria by inducing loss of mitochondrial membrane potential. Chrysanthemin also led to 
increase inthe activity of all three caspases viz., caspase-3, 8 and 9 in a dose-dependent fashion. 
 Apoptosis, also known as programmed cell death is a highly efficient, systematized and well regulated 
biochemical process involved in the eradication of unwanted dead cells from the body (Wang et al., 2014; Jie-Jie et al., 
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2015). Apoptosis process is regulated by a set of closely related enzymes including caspases and proteins of Bcl-2 family. It 
has been reported earlier that caspases including caspase-3, caspase-8 and caspase-9 play central roles in executing the 
process of apoptosis (Wang and Lenardo., 2000). Whereas caspase-9 was involved in the initiation of the apoptotic cascade, 
caspase-3 as the actual executioner of the apoptotic process leading to mostly mitochondrial mediated apoptosis. As such, 
with this in mind, the process of apoptosis induction in cancer cells can be readily demonstrated by evaluating the protein 
expressions of these caspase enzymes (Adams & Cory., 2002; Slee et al., 2001; Zhang et al., 2000). Chrysanthemin, which 
is the 3-glucoside of cyanidin belongs to the anthocyanin class of natural products. It can be isolated from various plants 
including Hibiscus sabdariffa, Rhaponticum species and some Viburnum species. It also occurs in various food plants 
including European elderberry, peach, lychee and soybean seed coats (Yoshitama et al., 1972; Vereskovskii and 
Chekalinskaya., 1978; Choung et al., 2001). No previous published reports could be seen documenting the anticancer 
effects of this naturally occurring anthocyanin in human prostate cancer cells. As such, the present research work is the first 
of such report on the antitumor effects of chrysanthemin.  
 In conclusion, it may be summarized that anticancer effects of chrysanthemin are induced in PC-3 human prostate 
cancer cells via the apoptosis induction, loss of mitochondrial membrane potential and activation of caspase-3, caspase-8 
and caspase-9 enzymes.  
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